Investor Relations

Latest Financial Results

Q2 2026

Quarter Ended Jun 30, 2026

Investor Presentation

Investor Presentation

Company Overview

SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas.

View Management Team View Board of Directors

Stock Information

SCYNEXIS, Inc.

Contact Us

Company

SCYNEXIS, Inc.
1 Evertrust Plaza
13th Floor
Jersey City, NJ 07302
T: (201) 884-5485
info@scynexis.com

Investor Relations

LifeSci Advisors
John Fraunces
T: 917-355-2395
jfraunces@lifesciadvisors.com

Transfer Agent

American Stock Transfer & Trust Company, LLC
10150 Mallard Creek Road
Suite 307
Charlotte, NC 28262
T: 800-937-5449